Table 2.
Factors associated with serum IL-6 in COVID-19 patients based on multivariate linear regression analysis.
| Estimate | SE | β | t value | p value | |
|---|---|---|---|---|---|
| Age | 0.234 | 0.205 | 0.095 | 1.14 | 0.254 |
| Sex | 4.122 | 3.513 | 0.081 | 1.17 | 0.241 |
| Obesity (BMI > 30 kg/m2) | −1.455 | 6.104 | −0.016 | −0.24 | 0.811 |
| Hypertension | 1.747 | 4.319 | 0.032 | 0.40 | 0.686 |
| Dyslipidemia | 3.671 | 4.402 | 0.056 | 0.83 | 0.405 |
| Diabetes mellitus | −10.150 | 5.872 | −0.120 | −1.73 | 0.085 |
| Hyper uric acid | 2.618 | 9.232 | 0.018 | 0.28 | 0.776 |
| Asthma | 2.866 | 5.650 | 0.032 | 0.51 | 0.612 |
| COPD | 4.695 | 8.281 | 0.038 | 0.57 | 0.571 |
| Chronic heart failure | −0.906 | 7.015 | −0.012 | −0.17 | 0.861 |
| Immunodeficiency | −16.266 | 5.185 | −0.150 | −2.32 | 0.021 |
| Smoking history | 9.380 | 6.755 | 0.108 | 1.39 | 0.283 |
β β standardized coefficient, BMI body mass index, COPD chronic obstructive pulmonary disease, SE standardized error.